Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06291766
Other study ID # 2022-05498-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date December 2035

Study information

Verified date February 2024
Source Region Skane
Contact Ulrika Moll, MD, PhD
Phone +46733307170
Email ulrika.moll@skane.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this trial is to compare different means of glucose monitoring in women with gestational diabetes and a history of gastric bypass surgery. The main question it aims to answer is: How does continous glucose monitoring impact the treatment and affect pregnancy outcome in these women. Participants will be randomized to either continous glucose monitoring or regular capillary glucose measurements during the last trimester of their pregnancy. Researchers will compare the glucose measurement outcomes, the glucose lowering treatment given and pregnancy outcomes between groups.


Description:

The project aims to investigate gestational diabetes in women with a history of gastric bypass surgery (GBP). The investigators will analyse glucose levels by using continuous glucose measurement (GCM) or capillary glucose measurements and compare mean glucose values, treatment and the pregnancy outcome. In Sweden the incidence of gestational diabetes is 2-5% of pregnancies, but the frequency varies greatly in different areas and in different ethnicities. The women with gestational diabetes have an increased risk of complications during pregnancy. The most acknowledged complications are large for gestational age infants (LGA), preeclampsia and caesarean section. The infants have a higher need for neonatal intensive care, due to the risk of hypoglycaemia, hypoxia and jaundice postpartum. Treating gestational diabetes and normalizing glucose values have been proven to reduce risks of unfavourable pregnancy outcome. Gastric bypass surgery is a common treatment for obesity. The frequency of young women with gastric bypass surgery and concomitant gestational diabetes have increased. Many maternity care centres have started to use a 3-7 day screening for gestational diabetes, since the routine oral glucose toleration test (OGTT) is not recommended after GBP. It is previously shown that women with GBP have a decreased risk of GDM and LGA infants. However, there is an increased risk of small for gestational age (SGA). There is a lack of knowledge and guidelines regarding the optimal treatment of gestational diabetes in these women. How the glucose variability affects pregnancy outcome is poorly investigated. At Lund University Hospital, Region Skane, Sweden, the screening procedure used since 2012 for GDM-screening in women with GBP is a 3 day 7-point capillary glucose measurement. Approximately 25% of the pregnant women with GBP is diagnosed with GDM, using this method at Lund University Hospital. In this project the investigators will randomize women with gestational diabetes and a history of gastric bypass (GDM-GBP) into two different groups in the last trimester of pregnancy. Both groups are given standard medical care, which includes visits to the Specialized Maternity Care Unit and weekly follow up by the diabetologist. The first group is given continuous glucose measurement (FreeStyle Libre3) and the other group is given standard medical care which includes 7-point capillary glucose measurement. With the CGM system it is possible to collect more comprehensive data regarding glucose values and variability. Previous studies have shown that women with gastric bypass surgery have an earlier than normal postprandial glucose excursion and are more prone to later postprandial hypoglycaemia. During this study, the physician as well as the patient can observe the early glucose excursion after meals and measure time in target, time above target and time below target. Large for gestational age and accelerated growth of the infant is supposed to be due to high glucose values and a high proportion of Time above target. The increased risk of SGA infants in these women is hypothesized to be due to a large proportion of time below target. However, this theory is not sufficiently investigated and it is not known if the use of CGM can help to reduce the risk of weight deviation in the infants. The investigators want to examine if new technique in glucose measurement can contribute to more favourable pregnancy outcome in women with gestational diabetes and a history of GDM. The main question is if the use of CGM affect pregnancy outcome. The secondary outcomes includes glucose variability and the use of different treatment approaches in GDM in this group of women.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 2035
Est. primary completion date December 2028
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Understands written and spoken Swedish - Previous Gastric Bypass surgery - Diagnosed with gestational diabetes according to our local criteria - Planned follow up at the Specialized Maternity Ward at Skane University Hospital - Understands the use of CGM and is willing to use the system - Have signed informed consent Exclusion Criteria: - Other kinds of bariatric surgery

Study Design


Intervention

Device:
FreeStyle Libre 2, continous glucose monitoring
The use of FreeStyle Libre 3 sensors and Libre Link app and Glooko app for analysing glucose control in pregnancy

Locations

Country Name City State
Sweden Region Skane Lund

Sponsors (1)

Lead Sponsor Collaborator
Region Skane

Country where clinical trial is conducted

Sweden, 

References & Publications (1)

Moll U, Landin-Olsson M, Nilsson C, Ursing D, Strevens H. Pregnancy outcome in women with gestational diabetes - A longitudinal study of changes in demography and treatment modalities. Acta Obstet Gynecol Scand. 2020 Mar;99(3):333-340. doi: 10.1111/aogs.13758. Epub 2019 Dec 22. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Adverse Pregnancy Outcome ANY: Caesarian section (Y/N), instrumental delivery (Y/N), preeclampsia (Y/N), premature birth before week 37 (Y/N), Macrosomia (>4000g) (Y/N), Large for gestational age infant (Y/N), small for gestational age infant (Y/N), shoulder dystocia (Y/N), neonatal hypoglycemia (Y/N) (<4 hours after birth: <1.4 mmol/L; 4 to <24 hours after birth: <1.9 mmol/L; 24 to <48 hours after birth: <2.8 mmol/L, =48 hours after birth: 3.3 mmol/L During delivery and postpartum (measured up to 5 days postpartum)
Secondary Glucose values Mean/median glucose values (mmol/l) Gestational week 28-42
Secondary Glucose values Glucose variability (SD) Gestational week 28-42
Secondary Glucose values % Time in Target (3,5-7,8 mmol/l) Gestational week 28-42
Secondary Glucose values % Time below target Gestational week 28-42
Secondary Glucose values % Time above target Gestational week 28-42
Secondary Pharmacological treatment The use of insulin (Y/N) Gestational week 28-42
Secondary Pharmacological treatment the dose of insulin (IE) Gestational week 28-42
Secondary Pharmacological treatment the use of Metformin (Y/N) Gestational week 28-42
Secondary Pharmacological treatment the dose of metformin (g/day) Gestational week 28-42
Secondary Birthweight birth weight of infant (g) at the day of birth
Secondary Week of delivery gestational week exact day (ie 28+0 to 42+6)
See also
  Status Clinical Trial Phase
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06437782 - Exploration of Health Literacy in Diabetes in Reunion Island and France
Completed NCT01940003 - Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial N/A
Completed NCT02960295 - The Virtual Visit for Women With Gestational Diabetes N/A
Completed NCT01919476 - Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women N/A
Completed NCT05512871 - A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM) N/A
Enrolling by invitation NCT03307486 - Gestational Diabetes: a Cohort Study N/A
Active, not recruiting NCT04417452 - Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
Completed NCT02968628 - Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
Active, not recruiting NCT04222348 - MeDiGes Study: Metformine Use in Gestational Diabetes Phase 3
Completed NCT03007186 - Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
Completed NCT00069576 - Gestational Diabetes Mellitus Trial (GDM) N/A
Completed NCT04866823 - Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes N/A
Recruiting NCT04198857 - Development and Testing of a Mobile Health Application for Management of Gestational Diabetes N/A
Recruiting NCT05115188 - DIAgnosing GDM usiNg Oral Sugar InStead Phase 2
Recruiting NCT03607799 - A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes N/A
Recruiting NCT02893072 - Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study N/A
Enrolling by invitation NCT05368220 - Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Completed NCT02770079 - Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
Completed NCT00681460 - Metformin in Gestational Diabetes Mellitus N/A